Literature DB >> 1727380

Specific binding to protein kinase C by ingenol and its induction of biological responses.

C M Hasler1, G Acs, P M Blumberg.   

Abstract

We have examined the ability of ingenol to bind to and activate protein kinase C and to induce similar responses to the phorbol esters in biological systems. The rationale was that ingenol possesses the critical functionalities of the phorbol ester pharmacophore with the exception of the hydrophobic domain; it might therefore possess weak potency, although previous reports had indicated that ingenol was biologically inactive. Our data demonstrate that ingenol indeed binds to protein kinase C with a Ki of 30 microM and activates the enzyme. In addition, ingenol was biologically active in 3 separate cell systems, showing effects similar to the phorbol esters on morphological change, cell-cell communication, epidermal growth factor binding, arachidonic acid metabolite release, and ornithine decarboxylase activity. The 50% effective concentration values for the biological activity of ingenol were between 30 microM and 1 mM, varying somewhat with the cell system and type of response. The biological activity of ingenol in general supports the proposed models of the phorbol ester pharmacophore and imposes additional experimental constraints that the modeling must satisfy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727380

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products.

Authors:  Zachary G Brill; Matthew L Condakes; Chi P Ting; Thomas J Maimone
Journal:  Chem Rev       Date:  2017-03-15       Impact factor: 60.622

2.  Protein kinase C controls lysosome biogenesis independently of mTORC1.

Authors:  Yang Li; Meng Xu; Xiao Ding; Chen Yan; Zhiqin Song; Lianwan Chen; Xiahe Huang; Xin Wang; Youli Jian; Guihua Tang; Changyong Tang; Yingtong Di; Shuzhen Mu; Xuezhao Liu; Kai Liu; Ting Li; Yingchun Wang; Long Miao; Weixiang Guo; Xiaojiang Hao; Chonglin Yang
Journal:  Nat Cell Biol       Date:  2016-09-12       Impact factor: 28.824

3.  Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate.

Authors:  M Fujiwara; K Ijichi; K Tokuhisa; K Katsuura; S Shigeta; K Konno; G Y Wang; D Uemura; T Yokota; M Baba
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Toxic and aversive diterpenes of Euphorbia esula.

Authors:  Fathi T Halaweish; Scott Kronberg; Mindy B Hubert; James A Rice
Journal:  J Chem Ecol       Date:  2002-08       Impact factor: 2.626

5.  Oxidopyrylium [5+2] Cycloaddition Chemistry: Historical Perspective and Recent Advances (2008-2018).

Authors:  Lauren P Bejcek; Ryan P Murelli
Journal:  Tetrahedron       Date:  2018-04-05       Impact factor: 2.457

6.  Potential aversive compounds in leafy spurge for ruminants and rats.

Authors:  S L Kronberg; W C Lynch; C D Cheney; J W Walker
Journal:  J Chem Ecol       Date:  1995-10       Impact factor: 2.626

7.  Interactions between Euphorbia esula toxins and bovine ruminal microbes.

Authors:  Scott L Kronberg; Fathi T Halaweish; Mindy B Hubert; Paul J Weimer
Journal:  J Chem Ecol       Date:  2006-02-26       Impact factor: 2.626

Review 8.  Wealth of opportunity - the C1 domain as a target for drug development.

Authors:  P M Blumberg; N Kedei; N E Lewin; D Yang; G Czifra; Y Pu; M L Peach; V E Marquez
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

9.  Ingenol Protects Human T Cells From HIV-1 Infection.

Authors:  Kee-Jong Hong; Hak Sung Lee; Yeong-Shik Kim; Sung Soon Kim
Journal:  Osong Public Health Res Perspect       Date:  2011-08-03

10.  Differential Regulation of Gene Expression in Lung Cancer Cells by Diacyglycerol-Lactones and a Phorbol Ester Via Selective Activation of Protein Kinase C Isozymes.

Authors:  Mariana Cooke; Victoria Casado-Medrano; Jihyae Ann; Jeewoo Lee; Peter M Blumberg; Martin C Abba; Marcelo G Kazanietz
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.